Nurse Practitioner · Valdosta, GA
NPI
1962944728
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
2501 N Patterson St
Valdosta, GA, 31602
Phone (229) 333-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
3,327 services
Medicare patients, 2024
239
Average age 71
Drug cost, 2024
$2.3M
5,369 prescriptions
Company payments, 2025
$1,560
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberlee Fletcher was code 99214 (office e&m - established), 354 times for 228 patients. In total Kimberlee Fletcher billed 3,327 services in 15 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 354 | 228 | $75.40 | $27K |
| 83036 Blood Count | Office | 307 | 212 | $9.38 | $2,881 |
| 95251 Test - Miscellaneous | Office | 216 | 156 | $21.39 | $4,620 |
| 82947 Clinical Chemistry | Office | 156 | 116 | $3.78 | $589 |
| 36415 Venipuncture Blood Collection | Office | 39 | 35 | $8.65 | $337 |
By year: 2022 $38K for 1,079 services; 2023 $39K for 1,175 services; 2024 $37K for 3,327 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 307 | 212 | $9.38 | $2,881 |
| 82947 Clinical Chemistry | 156 | 116 | $3.78 | $589 |
| 36415 Venipuncture Blood Collection | 39 | 35 | $8.65 | $337 |
Medicare prescription drug claims, 2024
In 2024, the drug Kimberlee Fletcher prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 342 prescriptions and refills. In total Kimberlee Fletcher wrote 5,369 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 342 | 374 | 92 | $391K |
| Metformin Hcl Er Metformin Hcl | 290 | 565 | 82 | $3,125 |
| Ozempic Semaglutide | 284 | 348 | 92 | $333K |
| Jardiance Empagliflozin | 278 | 460 | 72 | $269K |
| Atorvastatin Calcium Generic | 240 | 524 | 82 | $2,088 |
| Farxiga Dapagliflozin Propanediol | 225 | 356 | 62 | $201K |
| Trulicity Dulaglutide | 186 | 227 | 56 | $223K |
| Pioglitazone Hcl Generic | 158 | 304 | 45 | $1,172 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 157 | 327 | 67 | $26K |
| Levothyroxine Sodium Generic | 155 | 297 | 51 | $1,064 |
| Tresiba Flextouch U-100 Insulin Degludec | 151 | 359 | 63 | $119K |
| Nateglinide Generic | 121 | 207 | 31 | $6,588 |
| Rosuvastatin Calcium Generic | 118 | 231 | 39 | $1,375 |
| Metformin Hcl Generic | 114 | 202 | 42 | $670 |
| Losartan Potassium Generic | 113 | 233 | 35 | $778 |
Brand drugs: 2,755 claims; generic drugs: 2,240 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kimberlee Fletcher $1,560 ($1,560 in general payments such as food, travel and fees) from 15 companies. The largest payer was Medtronic, Inc. with $682.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 9 | $682 |
| Novo Nordisk Inc NVO | 11 | $220 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $98.96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95.41 |
| Abbott Laboratories ABT | 4 | $88.17 |
| Dexcom, Inc. DXCM | 3 | $62.1 |
| Corcept Therapeutics CORT | 3 | $60.08 |
| Lilly USA, LLC LLY | 3 | $57.51 |
| Amgen Inc. AMGN | 2 | $36.33 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $35.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.